Detalhe da pesquisa
1.
A randomised phase II study of osimertinib and bevacizumab versus osimertinib alone as second-line targeted treatment in advanced NSCLC with confirmed EGFR and acquired T790M mutations: the European Thoracic Oncology Platform (ETOP 10-16) BOOSTER trial.
Ann Oncol
; 33(2): 181-192, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34839016
2.
Pan-Asian adapted Clinical Practice Guidelines for the management of patients with metastatic non-small-cell lung cancer: a CSCO-ESMO initiative endorsed by JSMO, KSMO, MOS, SSO and TOS.
Ann Oncol
; 30(2): 171-210, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30596843
3.
Randomized controlled trial of S-1 versus docetaxel in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy (East Asia S-1 Trial in Lung Cancer).
Ann Oncol
; 28(11): 2698-2706, 2017 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29045553
4.
Phase I and biomarker study of OPB-51602, a novel signal transducer and activator of transcription (STAT) 3 inhibitor, in patients with refractory solid malignancies.
Ann Oncol
; 26(5): 998-1005, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25609248
5.
The frequency and impact of ROS1 rearrangement on clinical outcomes in never smokers with lung adenocarcinoma.
Ann Oncol
; 24(9): 2364-70, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23788756
6.
Can population differences in chemotherapy outcomes be inferred from differences in pharmacogenetic frequencies?
Pharmacogenomics J
; 13(5): 423-9, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22733238
7.
The value of disease-free survival (DFS) and osimertinib in adjuvant non-small-cell lung cancer (NSCLC): an international Delphi consensus report.
ESMO Open
; 7(5): 100572, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36108559
8.
Impact of smoking status on the relative efficacy of the EGFR TKI/angiogenesis inhibitor combination therapy in advanced NSCLC-a systematic review and meta-analysis.
ESMO Open
; 7(3): 100507, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35696746
9.
Phase I and pharmacodynamic study of an orally administered novel inhibitor of histone deacetylases, SB939, in patients with refractory solid malignancies.
Ann Oncol
; 22(11): 2516-2522, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21385886
10.
Prognostic significance of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase protein expression in colorectal cancer patients treated with or without 5-fluorouracil-based chemotherapy.
Ann Oncol
; 19(5): 915-9, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18245778
11.
Prognostic value of different CT measurements in early therapy response evaluation in patients with metastatic colorectal cancer.
Cancer Imaging
; 12: 212-24, 2012 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-22750105
12.
Non-small cell lung cancer presenting with neoplastic fever at diagnosis and relapse.
Int J Infect Dis
; 14(6): e518-21, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19699672
13.
A multicentre randomised phase II study of carboplatin in combination with gemcitabine at standard rate or fixed dose rate infusion in patients with advanced stage non-small-cell lung cancer.
Ann Oncol
; 17(7): 1128-33, 2006 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16670205
14.
Paclitaxel, 5-fluorouracil and hydroxyurea concurrent with radiation in locally advanced nasopharyngeal carcinoma.
Ann Oncol
; 17(7): 1152-7, 2006 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16684789
15.
Celecoxib reduces microvessel density in patients treated with nasopharyngeal carcinoma and induces changes in gene expression.
Ann Oncol
; 17(11): 1625-30, 2006 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17008411
16.
Hickman catheter complications in a haematology unit, 1996-98.
Intern Med J
; 32(3): 100-3, 2002 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-11885834